| [1] |
Read RL, Flitcroft K, Snook KL, et al.Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer [J].ANZ J Surg,2015,85(5):315-320.
|
| [2] |
Rastogi P, Anderson SJ, Bear HD, et al.Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27 [J].J Clin Oncol,2008,26(5):778-785.
|
| [3] |
Mamounas EP, Anderson SJ, Dignam JJ, et al.Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27 [J].J Clin Oncol, 2012,30(32):3960-3966.
|
| [4] |
Petersen RP, Truong PT, Kader HA, et al.Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance[J].Int J Radiat Oncol Biol Phys,2007,69(1):41-48.
|
| [5] |
Mansel RE, Fallowfield L, Kissin M, et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial [J].J Natl Cancer Inst,2006,98(9):599-609.
|
| [6] |
Chen AM, Meric-Bernstam F, Hunt KK, et al.Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience [J].J Clin Oncol,2004,22(12):2303-2312.
|
| [7] |
Min SY, Lee SJ, Shin KH, et al.Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy [J].Int J Radiat Oncol Biol Phys,2011,81(5): e697-705.
|
| [8] |
Earl HM, Hiller L, Dunn JA, et al.Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil,epirubicin,and cyclophosphamide,for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised,phase 3 trial [J].Lancet Oncol,2015,16(6):656-666.
|
| [9] |
Shinde AM, Zhai J, Yu KW, et al.Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab [J].Breast,2015,24(1):18-23.
|
| [10] |
van der Hage JA, van de Velde CJ, Julien JP, et al.Preoperative chemotherapy in primary operable breast cancer:results from the European Organization for Research and Treatment of Cancer trial 10902 [J].J Clin Oncol, 2001,19(22):4224-4237.
|
| [11] |
Garg AK, Buchholz TA.Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer [J].Ann Surg Oncol,2015,22(5):1434-1440.
|
| [12] |
Clarke M, Collins R, Darby S, et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials [J].Lancet,2005,366(9503):2087-2106.
|
| [13] |
Poortmans P.Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate [J].Lancet,2014,383(9935):2104-2106.
|
| [14] |
Buchholz TA, Katz A, Strom EA, et al.Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy [J].Int J Radiat Oncol Biol Phys,2002,53(4):880-888.
|
| [15] |
McGuire SE, Gonzalez-Angulo AM, Huang EH, et al.Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy [J].Int J Radiat Oncol Biol Phys,2007,68(4):1004-1009.
|
| [16] |
Gianni L, Eiermann W, Semiglazov V, et al.Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort [J].Lancet,2010,375(9712):377-384.
|
| [17] |
Garg AK, Strom EA, McNeese MD, et al.T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage Ⅱ breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy [J].Int J Radiat Oncol Biol Phys,2004,59(1):138-145.
|
| [18] |
Shim SJ, Park W, Huh SJ, et al.The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage Ⅱ-Ⅲbreast cancer patients with pN0: a multicenter,retrospective study (KROG 12-05) [J].Int J Radiat Oncol Biol Phys,2014,88(1):65-72.
|
| [19] |
Le Scodan R, Selz J, Stevens D, et al.Radiotherapy for stageⅡand stage Ⅲbreast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy [J].Int J Radiat Oncol Biol Phys,2012,82(1): e1-7.
|
| [20] |
Nagar H, Mittendorf EA, Strom EA, et al.Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer [J].Int J Radiat Oncol Biol Phys, 2011,81(3):782-787.
|